Analyst Reco. Celldex Therapeutics, Inc.

Equities

CLDX

US15117B2025

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-14 pm EDT			5-day change	1st Jan Change
34.67 ^USD	-4.83%		-1.73%	-12.58%

Jun. 11	Celldex Therapeutics Insider Sold Shares Worth $1,586,844, According to a Recent SEC Filing	MT
Jun. 11	Celldex Therapeutics Insider Sold Shares Worth $525,873, According to a Recent SEC Filing	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Celldex Therapeutics Insider Sold Shares Worth $1,586,844, According to a Recent SEC Filing	Jun. 11	MT
Celldex Therapeutics Insider Sold Shares Worth $525,873, According to a Recent SEC Filing	Jun. 11	MT
Wolfe Research Initiates Coverage on Celldex Therapeutics With Outperform Rating, $51 Price Target	Jun. 11	MT
Celldex Therapeutics Insider Sold Shares Worth $1,579,353, According to a Recent SEC Filing	Jun. 05	MT
Celldex Therapeutics Insider Sold Shares Worth $1,964,088, According to a Recent SEC Filing	Jun. 05	MT
Celldex Therapeutics Insider Sold Shares Worth $1,191,775, According to a Recent SEC Filing	Jun. 03	MT
Celldex Therapeutics Insider Sold Shares Worth $1,319,156, According to a Recent SEC Filing	Jun. 03	MT
Celldex Therapeutics Insider Sold Shares Worth $1,298,384, According to a Recent SEC Filing	Jun. 03	MT
TD Cowen Initiates Celldex Therapeutics at Outperform Rating	Dec. 20	MT
Wells Fargo Upgrades Celldex Therapeutics to Equalweight From Underweight With $27 Price Target	Nov. 10	MT
HC Wainwright Adjusts Price Target on Celldex Therapeutics to $80 From $73, Maintains Buy Rating	Nov. 06	MT
Rate Cut Hopes Push Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday	Nov. 06	MT
Wells Fargo Starts Celldex Therapeutics With Underweight Rating, $21 Price Target	23-08-22	MT
ANALYST RECOMMENDATIONS : Applovin, BAE Systems, Evercore, Jefferies, Target...	23-08-22
Guggenheim Adjusts Price Target on Celldex Therapeutics to $63 From $68, Maintains Buy Rating	22-11-11	MT
SVB Securities Adjusts Celldex Therapeutics' Price Target to $64 From $68, Keeps Outperform Rating	22-08-09	MT
HC Wainwright Adjusts Celldex Therapeutics' Price Target to $73 from $60, Keeps Buy Rating	22-07-01	MT
CELLDEX THERAPEUTICS : Jefferies & Co Reinstates Coverage on Celldex Therapeutics With Buy Rating, $66 Price Target	21-09-17	MT
ANALYST RECOMMENDATIONS : Autoliv, Fortinet, Tesla, Virgin Galactic, WP Carey...	21-09-17
CELLDEX THERAPEUTICS : HC Wainwright Adjusts Celldex Therapeutics PT to $60 From $54, Maintains Buy Rating	21-09-13	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Celldex Therapeutics, Inc.

Equities

CLDX

US15117B2025

Analyst Reco.

Filters